muscle loss with tirzepatide Tirzepatide‐induced body composition changes: Implications from the SURPASS‐3 MRI substudy Weight loss and muscle loss. – Understanding Muscle Loss with GLP1

Patients with a personal or family history of medullary thyroid carcinoma should avoid semaglutide entirely, as the medication carries a contraindication in this population

Long-Term Benefits The long-term benefits of Tirzepatide extend beyond weight loss and improved blood sugar control

Sohal, who will perform a complete history and physical

Mechanism of Action Comparison# Retatrutide# Retatrutide (LY3437943) is a 39-amino acid synthetic peptide that simultaneously activates three metabolically important receptors: GLP-1 receptor : Enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite through hypothalamic and brainstem signaling GIP receptor : Potentiates insulin secretion, may improve beta-cell survival, and contributes to adipose tissue metabolism and central appetite regulation Glucagon receptor : Increases hepatic energy expenditure, promotes fatty acid oxidation in the liver, stimulates thermogenesis in brown adipose tissue, and enhances lipolysis The glucagon receptor component is the defining innovation

Furthermore, the Philippines Food and Drug Administration (FDA) has sanctioned its application as an adjunctive treatment to mitigate the neurotoxic effects of cisplatin chemotherapy[3]

However, the group receiving both AOD9604 and HA showed the most favorable results, suggesting a potential synergistic interaction